Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study.

Nina Odan,Yuichiro Kikawa,Hajime Matsumoto,Junya Minohata,Hirofumi Suwa,Takashi Hashimoto,Toshitaka Okuno,Masaru Miyashita,Masaru Saito,Kazuhiko Yamagami,Shintaro Takao

Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study.

2020

Nina Odan
Yuichiro Kikawa
Hajime Matsumoto
Junya Minohata
Hirofumi Suwa
Takashi Hashimoto
Toshitaka Okuno
Masaru Miyashita
Masaru Saito
Kazuhiko Yamagami
Shintaro Takao

Background:Clinical studies have shown that palbociclib improves progression-free survival in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2−) patients wit...

Keywords:

Internal medicine
Palbociclib
Neutrophil to lymphocyte ratio
Cancer
real world outcomes
Retrospective cohort study
Oncology
Medicine
Lactate dehydrogenase
advanced breast
Hormone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations